Showing results (121-130 of 142) with videos related to
Sort By:
Pageof 15
Medical and Pediatric Oncology|January 1, 1979
Combination chemotherapy for non-Hodgkin lymphomas: a ten year follow-up studyD M Hayes, T F Pajak, V Rege, et al.International Journal of Radiation Oncology, Biology, Physics|August 5, 2000
A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003K K Fu, T F Pajak, A Trotti, et al.Cancer|June 1, 1982
Effect of methanol extraction residue of Bacillus Calmette-Guerin in advanced Hodgkin's diseaseM R Cooper, T F Pajak, N I Nissen, et al.The New England Journal of Medicine|December 31, 1998
Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancerD P Kelsen, R Ginsberg, T F Pajak, et al.American Journal of Clinical Oncology|September 1, 2007
Microvessel density >or=60 does not predict for outcome after radiation treatment for locally advanced head and neck squamous cell carcinoma: results of a correlative study from the Radiation Therapy Oncology Group (RTOG) 90-03 TrialDouglas P Calvin, M E Hammond, Thomas F Pajak, et al.The New England Journal of Medicine|December 3, 2003
Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancerArlene A Forastiere, Helmuth Goepfert, Moshe Maor, et al.Cancer|November 1, 1982
Comparison of oral melphalan, CCNU, and BCNU with and without vincristine and prednisone in the treatment of multiple myeloma. Cancer and Leukemia Group B experienceG G Cornwell, T F Pajak, S Kochwa, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 28, 2012
Long-term results of RTOG 91-11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancerArlene A Forastiere, Qiang Zhang, Randal S Weber, et al.Cancer|January 15, 1980
Clinical trial of VP 16--213 (NSC 141540) I.V. twice weekly in advanced neoplastic disease: a study by the Cancer and Leukemia Group BN I Nissen, T F Pajak, L A Leone, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2009
Validation of lysyl oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma: Radiation Therapy Oncology Group trial 90-03Quynh-Thu Le, Jonathan Harris, Anthony M Magliocco, et al.Pageof 15